HLA-DRA and diffuse large B-cell lymphoma: Although HLA-DRA gene expression was recognized as an independent adverse prognosis factor for RFS in DLBCL 57, we did not find any association with patient outcome in PCNSL, a result that may be linked to the poorer overall outcome of patients with PCNSL compared to DLBCL 58.